beta-aminoethyl isothiourea has been researched along with Ventricular Fibrillation in 1 studies
beta-Aminoethyl Isothiourea: A radiation-protective agent that can inhibit DNA damage by binding to the DNA. It also increases the susceptibility of blood cells to complement-mediated lysis.
Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hajnal, A | 1 |
Nagy, O | 1 |
Litvai, A | 1 |
Papp, J | 1 |
Parratt, JR | 1 |
VĂ©gh, A | 1 |
1 other study available for beta-aminoethyl isothiourea and Ventricular Fibrillation
Article | Year |
---|---|
Nitric oxide involvement in the delayed antiarrhythmic effect of treadmill exercise in dogs.
Topics: Analysis of Variance; Animals; beta-Aminoethyl Isothiourea; Dog Diseases; Dogs; Hemodynamics; NG-Nit | 2005 |